Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule of Deferred Tax Assets and Liabilities (Details)

v3.25.3
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Sep. 30, 2025
Sep. 30, 2024
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 29,195,207 $ 26,754,767
Research and development credit carryforwards 2,789,965 3,129,222
Amortization 6,620,882 5,791,883
Share-based compensation 39,130 19,357
Operating lease liability 13,092 36,786
Accrued expenses and other 24,327 26,977
Section 163(j) disallowed interest expense 758,351 761,450
Foreign tax credits 218,400
Gross deferred tax assets 39,659,354 36,520,442
Less: valuation allowance (39,644,696) (36,480,967)
Deferred tax assets 14,658 39,475
Property and equipment (2,353) (4,782)
Operating lease right-of-use asset (12,305) (34,693)
Net deferred tax assets